We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
-18.26%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$859M
AUM Growth
-$274M
Cap. Flow
+$11.4M
Cap. Flow %
1.32%
Top 10 Hldgs %
49.67%
Holding
76
New
1
Increased
28
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
NEO icon
NeoGenomics
NEO
+$18.2M
2
SIBN icon
SI-BONE Inc
SIBN
+$15.4M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$13.1M
4
ATRC icon
AtriCure
ATRC
+$5.44M
5
AXGN icon
Axogen
AXGN
+$5.14M

Top Sells

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$28.4M
2
XENT
Intersect ENT, Inc
XENT
+$19.6M
3
STRO icon
Sutro Biopharma
STRO
+$13.7M
4
KRYS icon
Krystal Biotech
KRYS
+$7.61M
5
BCYC
Bicycle Therapeutics
BCYC
+$3.92M

Sector Composition

Rank Sector Weight
1 Healthcare 86.58%
2 Communication Services 8.2%
3 Energy 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
51
GSK
GSK
$104B
$547K 0.06%
10,059
– –
CI icon
52
Cigna
CI
$73.7B
$512K 0.06%
1,943
– –
CVS icon
53
CVS Health
CVS
$133B
$511K 0.06%
5,519
– –
WAT icon
54
Waters Corp
WAT
$37B
$508K 0.06%
1,536
– –
HUM icon
55
Humana
HUM
$43.7B
$500K 0.06%
1,068
– –
BDX icon
56
Becton Dickinson
BDX
$45.6B
$465K 0.05%
1,888
-47
-2% -$11.9K
NVST icon
57
Envista
NVST
$4.44B
$455K 0.05%
11,793
– –
AVTR icon
58
Avantor
AVTR
$9.32B
$454K 0.05%
14,596
– –
MCK icon
59
McKesson
MCK
$100B
$439K 0.05%
1,346
– –
GILD icon
60
Gilead Sciences
GILD
$162B
$414K 0.05%
6,705
– –
ITGR icon
61
Integer Holdings
ITGR
$4.12B
$413K 0.05%
5,846
– –
SYNH
62
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$411K 0.05%
5,736
– –
HOLX
63
DELISTED
Hologic
HOLX
$405K 0.05%
5,845
– –
PRGO icon
64
Perrigo
PRGO
$1.4B
$399K 0.05%
9,823
– –
NUVA
65
DELISTED
NuVasive, Inc.
NUVA
$386K 0.04%
7,850
– –
JNJ icon
66
Johnson & Johnson
JNJ
$618B
$384K 0.04%
2,161
– –
BAX icon
67
Baxter International
BAX
$13.5B
$381K 0.04%
5,929
– –
TAK icon
68
Takeda Pharmaceutical
TAK
$54.6B
$360K 0.04%
25,630
– –
ICUI icon
69
ICU Medical
ICUI
$4.21B
$335K 0.04%
2,039
– –
SNY icon
70
Sanofi
SNY
$103B
$333K 0.04%
6,650
– –
UHS icon
71
Universal Health Services
UHS
$10.2B
$206K 0.02%
2,050
– –
JYNT icon
72
The Joint Corp
JYNT
$118M
– –
-56,498
Closed -$2M
LITS
73
Lite Strategy Inc
LITS
$32.8M
– –
-226,252
Closed -$2.73M
STRO icon
74
Sutro Biopharma
STRO
$401M
– –
-167,250
Closed -$13.7M
MRTX
75
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-45,205
Closed -$3.72M
1 2
3
4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, First Light Asset Management held 76 positions worth $859M, down 24% from $1.13B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

First Light Asset Management's Q2 2022 filing shows 1 new, 28 increased, 18 reduced and 5 closed positions. Its largest new stake was iShares Russell 2000 Growth ETF: 13,242 shares worth $2.73M. The largest sale was Halozyme, an estimated $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 84% a quarter earlier, followed by Communication Services and Energy.

  • First Light Asset Management's largest Q2 2022 buy was iShares Russell 2000 Growth ETF: 13,242 shares worth $2.73M.
  • First Light Asset Management added most to NeoGenomics in Q2 2022, an estimated $18.2M increase.
  • First Light Asset Management's biggest Q2 2022 reduction was Halozyme, cutting an estimated $28.4M.
  • First Light Asset Management fully exited Intersect ENT, Inc in Q2 2022, selling an estimated $19.6M.
  • First Light Asset Management's ten largest holdings make up 50% of its $859M portfolio in Q2 2022.
  • First Light Asset Management opened 1 new position and closed 5 in Q2 2022.
  • First Light Asset Management's portfolio value fell 24% quarter-over-quarter to $859M.

Based on First Light Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.